Hims & Hers rolls out weight loss program with plans to include GLP-1 drugs

Hims & Hers, a digital health company, has launched a weight loss program that includes digital tracking tools, educational content, and access to medications. The program, called Weight Loss by Hims & Hers, is part of the company's virtual weight management initiative. 

Consumers subscribing to the program will receive personalised educational content through the Hims & Hers app, covering nutrition, mental health, movement recommendations, and sleep advice. The program incorporates digital tracking tools to monitor activity levels, food intake, hydration, and sleep. While the weight loss medications offered do not currently include GLP-1s, the company is considering their inclusion in the future when price and supply chain issues are addressed.

The virtual weight management program aims to provide an affordable approach to weight loss by addressing underlying factors such as nutrition, behaviour, movement, and medical treatment. Hims & Hers is taking a holistic approach by offering a combination of medications with active ingredients to suppress appetite and curb cravings. The program is personalised by licensed healthcare providers based on an individual's body, health history, and overall health and wellness goals. Hims & Hers aims to make weight loss treatment more accessible and sustainable, considering the challenges associated with the cost and supply constraints of certain weight loss medications.

Obesity is a common chronic health issue in the U.S., leading to or exacerbating other significant health challenges. Hims & Hers recognises the need for a comprehensive and affordable weight management program, leveraging digital health tools and personalised medication management. The company's expansion into weight management follows the trend of digital health companies addressing metabolic health and offering solutions for weight loss and chronic condition management.